Raras
Buscar doenças, sintomas, genes...
Pseudohipercalemia familiar
ORPHA:90044CID-10 · D58.8CID-11 · 3A10.3OMIM 609153DOENÇA RARA

Subtipo hereditário, leve e não hemolítico de estomatocitose hereditária que está associado a uma anomalia dependente da temperatura na permeabilidade da membrana dos glóbulos vermelhos ao potássio, que leva a níveis elevados de potássio in vitro em amostras armazenadas abaixo de 37°C. A FP não está associada a anormalidades hematológicas adicionais, embora os indivíduos afetados possam apresentar algumas anormalidades leves, como macrocitose.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

Subtipo hereditário, leve e não hemolítico de estomatocitose hereditária que está associado a uma anomalia dependente da temperatura na permeabilidade da membrana dos glóbulos vermelhos ao potássio, que leva a níveis elevados de potássio in vitro em amostras armazenadas abaixo de 37°C. A FP não está associada a anormalidades hematológicas adicionais, embora os indivíduos afetados possam apresentar algumas anormalidades leves, como macrocitose.

Publicações científicas
21 artigos
Último publicado: 2025 Feb

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
Unknown
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
0.0
Worldwide
Início
All ages
🏥
SUS: Cobertura mínimaScore: 15%
CID-10: D58.8
🇧🇷Dados SUS / DATASUS
PROCEDIMENTOS SIGTAP (1)
0202010317
Eletroforese de hemoglobinaslab_test
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

🩸
Sangue
2 sintomas
💪
Músculos
2 sintomas
🧠
Neurológico
1 sintomas

+ 7 sintomas em outras categorias

Características mais comuns

90%prev.
Hipercalemia
Muito frequente (99-80%)
55%prev.
Hipertensão
Frequente (79-30%)
55%prev.
Estomatocitose
Frequente (79-30%)
17%prev.
Aumento do volume corpuscular médio
Ocasional (29-5%)
17%prev.
Reticulocitose
Ocasional (29-5%)
3%prev.
Anemia hemolítica episódica
Raro (<5%)
12sintomas
Muito frequente (1)
Frequente (2)
Ocasional (2)
Muito raro (2)
Sem dados (5)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 12 características clínicas mais associadas, ordenadas por frequência.

HipercalemiaHyperkalemia
Muito frequente (99-80%)90%
HipertensãoHypertension
Frequente (79-30%)55%
EstomatocitoseStomatocytosis
Frequente (79-30%)55%
Aumento do volume corpuscular médioIncreased mean corpuscular volume
Ocasional (29-5%)17%
ReticulocitoseReticulocytosis
Ocasional (29-5%)17%

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2025
Total histórico21PubMed
Últimos 10 anos12publicações
Pico20224 papers
Linha do tempo
2025Hoje · 2026📈 2022Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

1 gene identificado com associação a esta condição. Padrão de herança: Autosomal dominant.

ABCB6ATP-binding cassette sub-family B member 6Disease-causing germline mutation(s) (gain of function) inTolerante
FUNÇÃO

ATP-dependent transporter that catalyzes the transport of a broad-spectrum of porphyrins from the cytoplasm to the extracellular space through the plasma membrane or into the vesicle lumen (PubMed:17661442, PubMed:23792964, PubMed:27507172, PubMed:33007128). May also function as an ATP-dependent importer of porphyrins from the cytoplasm into the mitochondria, in turn may participate in the de novo heme biosynthesis regulation and in the coordination of heme and iron homeostasis during phenylhydr

LOCALIZAÇÃO

Cell membraneMitochondrion outer membraneEndoplasmic reticulum membraneGolgi apparatus membraneEndosome membraneLysosome membraneLate endosome membraneEarly endosome membraneSecreted, extracellular exosomeMitochondrionEndosome, multivesicular body membraneMelanosome membrane

VIAS BIOLÓGICAS (1)
Mitochondrial ABC transporters
MECANISMO DE DOENÇA

Microphthalmia/Coloboma 7

A disorder of eye formation, ranging from small size of a single eye to complete bilateral absence of ocular tissues. Ocular abnormalities like opacities of the cornea and lens, scaring of the retina and choroid, and other abnormalities may also be present. Ocular colobomas are a set of malformations resulting from abnormal morphogenesis of the optic cup and stalk, and the fusion of the fetal fissure (optic fissure).

OUTRAS DOENÇAS (12)
microphthalmia, isolated, with coloboma 7familial pseudohyperkalemiadyschromatosis universalis hereditaria 3obsolete blood group, langereis system
HGNC:47UniProt:Q9NP58

Variantes genéticas (ClinVar)

84 variantes patogênicas registradas no ClinVar.

🧬 ABCB6: NM_005689.4(ABCB6):c.1531G>A (p.Ala511Thr) ()
🧬 ABCB6: NM_005689.4(ABCB6):c.2188G>A (p.Gly730Arg) ()
🧬 ABCB6: GRCh37/hg19 2q33.3-37.3(chr2:206965837-242783384)x3 ()
🧬 ABCB6: NM_005689.4(ABCB6):c.490G>A (p.Ala164Thr) ()
🧬 ABCB6: NM_005689.4(ABCB6):c.1806-16C>A ()
Ver todas no ClinVar

Classificação de variantes (ClinVar)

Distribuição de 8 variantes classificadas pelo ClinVar.

4
3
1
Patogênica (50.0%)
VUS (37.5%)
Benigna (12.5%)
VARIANTES MAIS SIGNIFICATIVAS
ABCB6: NM_005689.4(ABCB6):c.1511T>C (p.Val504Ala) [Conflicting classifications of pathogenicity]
ABCB6: NM_005689.4(ABCB6):c.1361T>C (p.Val454Ala) [Conflicting classifications of pathogenicity]
ABCB6: NM_005689.4(ABCB6):c.1123C>T (p.Arg375Trp) [Likely pathogenic]
ABCB6: NM_005689.4(ABCB6):c.1124G>A (p.Arg375Gln) [Pathogenic]
ABCB6: NM_005689.4(ABCB6):c.1864-4A>G [Uncertain significance]

Vias biológicas (Reactome)

2 vias biológicas associadas aos genes desta condição.

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Pseudohipercalemia familiar

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

Pesquisa e ensaios clínicos

Nenhum ensaio clínico registrado para esta condição.

🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
12 papers (10 anos)
#1

Hyperkalemia presentation at a clinic during the cold season.

CEN case reports2025 Feb

Familial pseudohyperkalemia (FP) is an underrecognized cause of pseudohyperkalemia, caused by the leaking of potassium from red blood cells. This extracellular shift of potassium is temperature-dependent and occurs when blood samples are stored below room temperature or for a long time, manifesting as apparent hyperkalemia. We report a suspicious case of FP, which demonstrated an apparent seasonal trajectory of serum-potassium levels at the local clinic. At first, laboratory test results did not show an increase in the serum-potassium levels in our tertiary hospital. However, by replicating the clinic's storage conditions, the patient's serum sample showed hyperkalemia only when it was stored at a temperature of 4 °C or 20 °C for 4-8 h. Hyperkalemia was not observed in the patient's sample when it was stored at 37 °C, or in the healthy control's sample at a temperature of 20 °C or 37 °C. When encountering hyperkalemia without an obvious cause and symptoms, physicians should consider pseudohyperkalemia in the differential diagnosis. In particular, if a seasonal trajectory of serum-potassium levels is observed, FP should be suspected as a potential cause of pseudohyperkalemia. Although a genetic test is needed to properly diagnose FP, confirming it by verifying the sample storage conditions or proving it by replicating the test using different storage conditions is easy and very important, as it can prevent unnecessary treatment.

#2

Marked hyperkalemia due to inappropriate blood sample storage in two suspected cases of familial pseudohyperkalemia.

CEN case reports2023 Nov

We herein report two suspected cases of pseudohyperkalemia who presented with severe hyperkalemia examined at small primary care clinics; however, re-exams at a tertiary care hospital showed normal potassium levels. We reproduced the laboratory examination conditions of the clinics and found that hyperkalemia was due to sampling/storage condition of serum, which is strongly suggestive of familial pseudohyperkalemia (FP). FP is a possible but under-appreciated cause of hyperkalemia, which does not require treatment, so it is important to include FP in the differential diagnosis of hyperkalemia especially in cases with discrepant of serum potassium levels at different settings.

#3

Sustained hyperkalemia in an asymptomatic primary care patient. When to suspect familial pseudohyperkalemia.

Advances in laboratory medicine2022 Oct

Study and management of a case with elevated potassium levels without apparent clinical causes in successive follow-up visits. We present the case of a primary care female patient who persistently exhibited elevated levels of potassium (5.3-5.9 mmol/L) in successive control laboratory tests, without an apparent clinical cause. The patient was ultimately referred to the Unit of Nephrology, where a potassium-low diet was indicated. Diet did not have any effect on potassium levels. After a thorough study, the cause of hyperkalemia could not be determined. The inconsistency between elevated potassium levels and the reason of consultation, and exclusion of other pre-analytical or pathological causes raised suspicion of familial pseudohyperkalemia. The sample was incubated at different times and temperatures to demonstrate their influence on levels of potassium in blood. Familial pseudohyperkalemia was established as the most probable diagnosis. Finally, the patient was discharged from the Unit of Nephrology and instructed to follow a normal diet.

#4

The compound effect of irradiation and familial pseudohyperkalemia on potassium leak from red blood cells.

Transfusion2022 Dec

Familial pseudohyperkalemia (FP) is a rare asymptomatic condition characterized by an increased rate of potassium leak from red blood cells (RBC) on refrigeration. Gamma irradiation compromises RBC membrane integrity and accelerates potassium leakage. Here, we compared the effect of irradiation, applied early or late in storage, on FP versus non-FP RBC. Five FP and 10 non-FP individuals from the National Institute for Health Research Cambridge BioResource, UK, and three FP and six non-FP individuals identified by Australian Red Cross Lifeblood consented to the study. Blood was collected according to standard practice in each center, held overnight at 18-24°C, leucocyte-depleted, and processed into red cell concentrates (RCC) in Saline Adenine Glucose Mannitol. On Day 1, RCC were split equally into six Red Cell Splits (RCS). Two RCS remained non-irradiated, two were irradiated on Day 1 and two were irradiated on Day 14. RBCs were tested over cold storage for quality parameters. As expected, non-irradiated FP RCS had significantly higher supernatant potassium levels than controls throughout 28 days of storage (p < .001). When irradiated early, FP RCS released potassium at similar rates to control. When irradiated late, FP RCS supernatants had higher initial post-irradiation potassium concentration than controls but were similar to controls by the end of storage (14 days post-irradiation). No other parameters studied showed a significant difference between FP and control. FP does not increase the rate of potassium leak from irradiated RBCs. Irradiation may cause a membrane defect similar to that in FP RBCs.

#5

[Pseudohyperkalemia: clinical chemistry for the clinician].

Nederlands tijdschrift voor geneeskunde2022 Jun 20

Hyperkalemia is an electrolyte disorder requiring medical attention because it can cause cardiac arrhythmias. Pseudohyperkalemia is the phenomenon of an elevated potassium concentration that is present in the blood sample but not in the patient. Pseudohyperkalemia can be caused by hemolysis, leukocytosis, thrombocytosis, seasonal pseudohyperkalemia, potassium release from muscle cells due to fist clenching during venipuncture, and contamination due to blood withdrawal from an intravenous line over which potassium was administered. Rarer causes include EDTA contamination and familial pseudohyperkalemia. A 23-year old woman was admitted with ascites due to polycythemia vera and essential thrombocytosis for which hydroxycarbamide was started. The reported serum potassium concentrations were 6.1 and 6.8 mmol/l. The use of spironolactone was discontinued and she was treated with sodium polystyrene sulfonate and insulin-glucose infusion. The serum potassium concentration only decreased on the ninth day of admission, when the thrombocyte count was normalizing. A diagnosis of pseudohyperkalemia due to thrombocytosis was established. Knowledge of the causes of pseudohyperkalemia and interaction between the clinician and clinical chemist aids in the differentiation between true hyperkalemia and pseudohyperkalemia and may prevent unnecessary diagnostics and harmful treatment.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC12 artigos no totalmostrando 12

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Pseudohipercalemia familiar.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Pseudohipercalemia familiar

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Hyperkalemia presentation at a clinic during the cold season.
    CEN case reports· 2025· PMID 38896354mais citado
  2. Marked hyperkalemia due to inappropriate blood sample storage in two suspected cases of familial pseudohyperkalemia.
    CEN case reports· 2023· PMID 36907981mais citado
  3. Sustained hyperkalemia in an asymptomatic primary care patient. When to suspect familial pseudohyperkalemia.
    Advances in laboratory medicine· 2022· PMID 37362145mais citado
  4. The compound effect of irradiation and familial pseudohyperkalemia on potassium leak from red blood cells.
    Transfusion· 2022· PMID 36285891mais citado
  5. [Pseudohyperkalemia: clinical chemistry for the clinician].
    Nederlands tijdschrift voor geneeskunde· 2022· PMID 35736384mais citado

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:90044(Orphanet)
  2. OMIM OMIM:609153(OMIM)
  3. MONDO:0012204(MONDO)
  4. GARD:16785(GARD (NIH))
  5. Variantes catalogadas(ClinVar)
  6. Busca completa no PubMed(PubMed)
  7. Q55999822(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Pseudohipercalemia familiar
Compêndio · Raras BR

Pseudohipercalemia familiar

ORPHA:90044 · MONDO:0012204
Prevalência
Unknown
Herança
Autosomal dominant
CID-10
D58.8 · Outras anemias hemolíticas hereditárias especificadas
CID-11
Início
All ages
Prevalência
0.0 (Worldwide)
MedGen
UMLS
C1836705
EuropePMC
Wikidata
Papers 10a
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades